0001062993-14-003742.txt : 20140624
0001062993-14-003742.hdr.sgml : 20140624
20140616172226
ACCESSION NUMBER: 0001062993-14-003742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140612
FILED AS OF DATE: 20140616
DATE AS OF CHANGE: 20140616
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gitman Paul
CENTRAL INDEX KEY: 0001375378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 14923622
MAIL ADDRESS:
STREET 1: 167 EXECUTIVE DRIVE
CITY: MANHASSET HILLS
STATE: NY
ZIP: 11040
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2014-06-12
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375378
Gitman Paul
167 EXECUTIVE DRIVE
MANHASSET HILLS
NY
11040
1
0
0
0
Common Stock, $0.001 par value
2014-06-12
4
M
0
10000
1
A
69425
D
Common Stock, $0.001 par value
2014-06-12
4
S
0
10000
28
D
59425
D
Stock Option (Right to Buy)
1
2014-06-12
4
M
0
10000
0
D
2006-01-23
2016-01-22
Common Stock, $0.001 par value
10000
10000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2013 as amended on December 17, 2013.
/s/ Paul Gitman by Carl A. Valenstein, attorney in fact
2014-06-16